Efficacy Results Favoring Carboplatin

John Bazar presents progression‑free and overall survival outcomes showing non‑inferiority and numerical benefit for carboplatin.

Play episode from 06:34

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!